研究论文
Pulmonary arterial hypertension: a long-standing and nonnegligible burden over three decades
Jiayong Qiu, Lu-Hong Qiu, Shen-Shen Huang, Bocheng Qiu, Chao Liu, Dong Ding, Yuejiao Ma, Yu‐Ping Zhou 等 16 位
Henan University of Science and Technology Second Hospital of Hebei Medical University First Affiliated Hospital of Henan University of Science and Technology Guangdong Academy of Medical Sciences
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF,后续可基于全文生成更完整的速读。
逐年被引趋势
210
225
26
关键指标
4
被引次数 · OpenAlex
1.90
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 16%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
15
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:文献信息
论文问答
当前基于文献信息回答
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Pulmonary Hypertension Research and Treatments
Vascular Anomalies and Treatments · Obstructive Sleep Apnea Research
参考文献 15
An epidemiological study of pulmonary arterial hypertension
被引 914Adrian Peacock, Niamh F Murphy, John J.V. McMurray · European Respiratory Journal · 2007
An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
被引 1,201Raymond L. Benza, Dave P. Miller, Robyn J. Barst · CHEST Journal · 2012
Epidemiology and treatment of pulmonary arterial hypertension
被引 563Edmund Lau, Eleni Giannoulatou, David Stephen Celermajer · Nature Reviews Cardiology · 2017
此处列出前 3 条
引用本文 4
Growth Differentiation Factor-15 Improves Prognostic Accuracy of Risk Stratification in Pulmonary Arterial Hypertension
被引 5An-Yi Wang, Jie‐Ling Ma, Yue Cui · CHEST Journal · 2025
Metabolic reprogramming in pulmonary arterial hypertension
被引 1Jun-Zhuo Shi, Jinze Ye, Xiao-Rui An · Pharmacology & Therapeutics · 2026
NF-κB signaling as a critical inflammatory node in pulmonary arterial hypertension: from vascular remodeling to right heart failure
被引 0Yan He, Yingying Zhu, Qihong Lv · Frontiers in Immunology · 2026
按被引量排序,此处列出前 3 条